全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

桃核承气汤干预非小细胞肺癌脑转移瘤的体内药效学研究进展
Research Progress of in Vivo Pharmacodynamics of Brain Metastasis from Non-Small Cell Lung Cancer Interfered by Taohe Chengqi Decoction

DOI: 10.12677/HJMCe.2020.83010, PP. 84-89

Keywords: 肺癌,脑转移,桃核承气汤,作用机制
Lung Cancer
, Brain Metastasis, Taohe Chengqi Decoction, Research Progress

Full-Text   Cite this paper   Add to My Lib

Abstract:

国内外研究现状对肺癌脑转移的发生发展,肺癌脑转移的中医认识,肺癌脑转移的治疗现状进行阐述。桃核承气汤加减方对脑胶质瘤细胞的增殖和侵袭有显著抑制作用;体内实验证明该方可以使荷瘤小鼠延长生存期。肺癌脑转移的病因病机复杂多样,与风之“变、动、快”特性一致。肺癌初期,正气亏损,风邪易犯,兼夹痰、瘀、毒上扰脑窍,聚而为瘤;后期因治疗及瘤体本身消耗,导致人体阴阳俱损、气失调畅,或肝逆动风,或脾虚生风,加重病情。在中医理论指导下,应用桃核承气汤对证干预肺癌脑转移瘤具有较高的可行性和较好的应用前景。
Research progress of the brain metastasis from non-small cell lung cancer would be elaborated, in-cluding the development, Chinese medical cognition and current status of treatment. Taohe Chengqi Decoction could dramatically inhibit the proliferation and invasion of brain glioma cells. It was demonstrated in in vivo experimentation that Taohe Chengqi Decoction could extend the lifetime of tumor-bearing rats. The cause and mechanism of lung cancer with brain metastases complex, re-sembling to the “change, movement and swiftness”, the character of wind. In the early stage of lung cancer, the deficiency of positive qi, the tendency of wind evil to commit, and the tumor forms com-bine with phlegm, blood stasis and toxin, and accumulation of tumor. In the later stage, the treat-ment and consumption of the tumor itself lead to the loss of both yin and yang of human body, the unobstructed qi, or the reverse of the liver to move the wind, or the deficiency of the spleen to gen-erate wind, thus aggravating the illness. It has high feasibility and application prospect that Taohe Chengqi Decoction can interfere the brain metastasis from non-small cell lung cancer.

References

[1]  Jemal, A. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90.
https://doi.org/10.3322/caac.20107
[2]  Kohler, B.A., Ward, E., McCarthy, B.J., et al. (2011) Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System. Journal of the National Cancer Institute, 103, 714-736.
https://doi.org/10.1093/jnci/djr077
[3]  Guessous, I., Cornuz, J., Paccaud, F., et al. (2007) Lung Cancer Screening: Current Situation and Perspective. Swiss Medical Weekly, 137, 304-311.
[4]  庞晓雯, 闵婕, 张贺龙. 非小细胞肺癌脑转移的研究与治疗进展[J]. 现代肿瘤医学, 2013, 21(2): 450-452.
[5]  Gaspar, L.E., Chansky, K., Albain, K.S., et al. (2005) Time from Treatment to Subsequent Diagnosis of Brain Metastases in Stage III Non-Small-Cell Lung Cancer: A Retrospective Review by the Southwest Oncology Group. Journal of Clinical Oncology, 23, 2955-2961.
https://doi.org/10.1200/JCO.2005.08.026
[6]  Hubbs, J.L., Boyd, J.A., Hollis, D., et al. (2010) Factors Associated with the Development of Brain Metastase: Analysis of 975 Patients with Early Stage Non-Small Cell Lung Cancer. Can-cer, 116, 5038-5046.
https://doi.org/10.1002/cncr.25254
[7]  Sajama, C., Lorenzoni, J. and Tagle, P. (2008) Diagnosis and Treatment of Brain Metastasis. Revista Médica de Chile, 136, 1321-1326.
https://doi.org/10.4067/S0034-98872008001000014
[8]  Netland, P.A. and Zetter, B.R. (1984) Organ-Specific Adhesion of Metastatic Tumor Cells in Vitro. Science, 224, 1113-1115.
https://doi.org/10.1126/science.6372098
[9]  Ortuzar, W. (2012) Brain Metastasis as the Primary Site of Relapse in Two Randomized Phase III Pemetrexed Trials in Advanced Non-Small-Cell Lung Cancer. Clinical Lung Cancer, 13, 24-30.
https://doi.org/10.1016/j.cllc.2011.05.007
[10]  Kraemer, B. (2011) Impaired Bone Microenvironment: Cor-relation between Bone Density and Presence of Disseminated Tumor Cells. Anticancer Research, 31, 4423-4428.
[11]  Baseri, B. (2012) Activation of Signaling Pathways Following Localized Delivery of Systemically Administered Neurotrophic Factors across the Blood-Brain Barrier Using Focused Ultrasound and Microbubbles. Phys-ics in Medicine & Biology, 57, N65-N81.
https://doi.org/10.1088/0031-9155/57/7/N65
[12]  Ningaraj, N.S., Rao, M., Ilashizume, K., et al. (2002) Regulation of Blood-Brain Tumor Barrier Permeability by Calcium-Activated Potassium Channels. Journal of Pharmacology and Experimental Therapeutics, 301, 838-851.
https://doi.org/10.1124/jpet.301.3.838
[13]  李晓霞, 李文良, 马勇杰. 肺癌脑转移分子机制的研究进展[J]. 中华肿瘤防治杂志, 2013, 20(5): 387-391.
[14]  Serizawa, T. (2009) Radiosurgery for Metastatic Brain Tumors. Interna-tional Journal of Clinical Oncology, 14, 289-298.
https://doi.org/10.1007/s10147-009-0910-7
[15]  Kim, H.R. (2012) Distinct Clinical Features and Outcomes in Never-Smokers with Nonsmall Cell Lung Cancer Who Harbor EGFR or KRAS Mutations or ALK Rearrangement. Cancer, 118, 729-739.
https://doi.org/10.1002/cncr.26311
[16]  Theoharides, T.C., Rozniecki, J.J., Sahagian, G., et al. (2008) Impact of Stress and Mast Cells on Brain Metastases. Journal of Neuroimmunology, 205, 1-7.
https://doi.org/10.1016/j.jneuroim.2008.09.014
[17]  徐妹丽, 金春梅, 宋琪. 榄香烯乳联合放疗治疗肺癌脑转移40例疗效分析[J]. 中外医疗, 2008, 27(18): 99-100.
[18]  李佩文. 肺癌的综合诊疗学[M]. 北京: 中国中医药出版社, 2000: 822-823.
[19]  周兴芹, 季斌, 仇晓军, 等. 榄香烯乳注射液联合放疗治疗肺癌脑转移的临床观察[J]. 临床肿瘤杂志, 2010, 15(11): 1014-1016.
[20]  张殿宝, 姚俊, 郭艳珍. 鸦胆子油乳联合放疗在非小细胞肺癌脑转移中的应用研究[J]. 中国医学创新, 2010, 7(7): 11-12.
[21]  张英, 侯炜, 林洪生, 等. 中医药治疗恶性肿瘤临床研究成果与思考[J]. 中医杂志, 2014, 55(6): 523-525.
[22]  杨文笑, 焦丽静, 龚亚斌, 许玲. 肺癌脑转移从“风”论治优[J]. 山东中医杂志, 2018, 37(3): 186-188.
[23]  崔慧娟. 肺癌的中西医结合治疗对策[M]. 北京: 化学工业出版社, 2007: 76-78.
[24]  王志字, 李光, 张晓萌, 等. 颅脑X刀治疗脑转移瘤临床疗效分[J]. 中华放射肿瘤学杂志, 2007, 16(1): 38-41.
[25]  李文玲. 神经系统肿瘤现代非手术治疗[M]. 北京: 科学技术文献出版社, 2008: 206-208.
[26]  朱世杰. 肺癌[M]. 北京: 科学技术文献出版社, 2004: 441.
[27]  Ting, C.Y. (2012) Concurrent Blood-Brain Barrier Opening and Local Drug Delivery Using Drug-Carrying Microbubbles and Focused Ultrasound for Brain Glioma Treatment. Biomaterials, 33, 704-712.
https://doi.org/10.1016/j.biomaterials.2011.09.096
[28]  MacDonell, L.A., Potter, P.E., Leslie, R.A., et al. (1978) Localized Changes in Blood-Brain Barrier Permeability Following the Administration of Antineoplastic Drugs. Cancer Research, 38, 2930-2934.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133